Showing results (151-160 of 337) with videos related to
Sort By:
Pageof 34
Frontiers in Cardiovascular Medicine|August 3, 2023
A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™Patrick L Iversen, Nicholas Kipshidze, Nodar Kipshidze, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 4, 2008
Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic applicationHe Zhu, Debra Hoppensteadt, Rakesh Wahi, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 21, 2025
Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia AMeganathan Kannan, Chitrali Laha Roy, Prakasha Kempaiah, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 23, 2024
Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a ComorbidityVanessa Robbin, Vinod Bansal, Kavitha Vellanki, et al.Hematology/Oncology Clinics of North America|January 22, 2008
Laboratory evaluation of the antiphospholipid syndromeDebra A Hoppensteadt, Nancy Fabbrini, Rodger L Bick, et al.Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparinsMichael John Knesek, Evangelos Litinas, Cafer Adiguzel, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markersMeganathan Kannan, Sarfraz Ahmad, Firdos Ahmad, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.Pageof 34